Statistics for Gain Therapeutics, (id:6902 GANX)

Valuation metrics

Market cap

43.15M

Enterprise value

30.98M

Trailing P/E (ttm)

-0.98

Forward P/E

-1.90

PEG ratio

-1.90

Price/Sales (ttm)

782.08

Price/Book (mrq)

2.18

Enterprise Value/Revenue

561.51

Enterprise Value/EBITDA

-1.42

Overview

Shares outstanding

25.54M

Float

24.23M

Shares short

658.34K

% Held by insiders

0.05%

% Held by institutions

0.08%

Average volume (10 days)

265.11K

Average volume (90 days)

Price summary

52-Week low

0.89

52-Week high

5.33

52-Week change

-31.76%

Beta

0.34

50-Day moving average

2.03

200-Day moving average

2.47

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-40,328.26%

Operational effectiveness

Return on assets

-72.96%

Return on equity

-188.83%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-21,823,828.00

Net income to common (ttm)

-21,599,504.00

Diluted EPS (ttm)

-1.31

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

16.94M

Total cash per share (mrq)

0.66

Total debt (mrq)

807.57K

Total Debt/Equity (mrq)

6.85

Current ratio (mrq)

284.20%

Book value per share (mrq)

0.78

Cash flow

Cash flow statement

-18,970,080.00

Levered free cash flow (LFCF)

-10,058,968.00